• Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the …
• Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing the Potential …
• Summary Safety Review - Viscous Lidocaine 2% - Assessing the Potential Risk …
• Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk of …
• Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk …